induced pluripotent stem cell-based allogenic cell therapies (Allogene Therapeutics/Notch Therapeutics)

N/A

Report date: 2024/01/02 15:20:13

Base Information

Drug Nameinduced pluripotent stem cell-based allogenic cell therapies (Allogene Therapeutics/Notch Therapeutics)
Drug Alias NameiPSC AlloCAR T™ cells (Allogene Therapeutics/Notch Therapeutics)
ClassificationCell and gene therapy > Cell therapy > Stem cell therapy > Induced pluripotent stem cells therapy
Mechanisms of ActionImmunologic cytotoxicityT lymphocyte replacements
TargetsNot applicable
Therapy Area/IndicationsHematologic Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryCanada
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesNotch Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesNotch Therapeutics IncAllogene Therapeutics Inc
Inactive CompaniesN/A
Active IndicationsHematologic Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A